Latest News on MDXG

Financial News Based On Company


Advertisement
Advertisement

MiMedx ( MDXG ) Q2 Earnings and Revenues Beat Estimates

https://www.zacks.com/stock/news/2640617/mimedx-mdxg-q2-earnings-and-revenues-beat-estimates
MiMedx (MDXG) delivered earnings and revenue surprises of +66.67% and +10.45%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026

https://www.globenewswire.com/news-release/2025/07/15/3115721/0/en/MIMEDX-Comments-on-Proposed-Medicare-Reimbursement-Rule-Changes-for-CY-2026.html
New Mechanism for the Reimbursement of Skin Substitutes Aimed at Curbing Fraud, Waste and Abuse New Mechanism for the Reimbursement of Skin Substitutes Aimed at Curbing Fraud, Waste and Abuse ...

Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Blue Gold ( NASDAQ:BGL ) , FB Financial ( NYSE:FBK )

https://www.benzinga.com/trading-ideas/movers/25/07/46413667/simulations-plus-fb-financial-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-sessi
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Tuesday. Shares of Simulations Plus, Inc SLP fell sharply in pre-market trading after the company reported downbeat third-quarter sales and cut its FY2025 EPS guidance.

Why Trade Desk Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - Ansys ( NASDAQ:ANSS ) , BloomZ ( NASDAQ:BLMZ )

https://www.benzinga.com/news/25/07/46411653/why-trade-desk-shares-are-trading-higher-by-15-here-are-20-stocks-moving-premarket
Shares of The Trade Desk, Inc. TTD rose sharply in pre-market trading following the announcement of its inclusion in the S&P 500 index. This development comes after the S&P Dow Jones Indices revealed that The Trade Desk would replace ANSYS Inc. ANSS in the S&P 500, effective from the market open ...

Strength Seen in MiMedx ( MDXG ) : Can Its 8.0% Jump Turn into More Strength?

https://www.zacks.com/stock/news/2568972/strength-seen-in-mimedx-mdxg-can-its-80-jump-turn-into-more-strength
MiMedx (MDXG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Advertisement

Eye On Growth: William F. Hulse as attorney-in-fact Dorothy Puhy Adds $185K Of MiMedx Group Stock To Portfolio - MiMedx Group ( NASDAQ:MDXG )

https://www.benzinga.com/insights/news/25/06/46076616/eye-on-growth-william-f-hulse-as-attorney-in-fact-dorothy-puhy-adds-185k-of-mimedx-group-stock-to-p
On June 23, a substantial insider purchase was made by William F. Hulse as attorney-in-fact Dorothy Puhy, Board Member at MiMedx Group MDXG, as per the latest SEC filing. What Happened: In a Form 4 filing on Monday with the U.S.

Bullish Move: Tiffany Olson Shows Confidence, Acquires $185K In MiMedx Group Stock - MiMedx Group ( NASDAQ:MDXG )

https://www.benzinga.com/insights/news/25/06/46076614/bullish-move-tiffany-olson-shows-confidence-acquires-185k-in-mimedx-group-stock
A notable insider purchase on June 23, was reported by Tiffany Olson, Board Member at MiMedx Group MDXG, based on the most recent SEC filing. What Happened: Olson made a significant move by purchasing 28,609 shares of MiMedx Group as reported in a Form 4 filing with the U.S.

Director Of MiMedx Group Makes $185K Buy - MiMedx Group ( NASDAQ:MDXG )

https://www.benzinga.com/insights/news/25/06/46076610/director-of-mimedx-group-makes-185k-buy
In a recent SEC filing, it was revealed that Cato T Laurencin, Director at MiMedx Group MDXG, made a noteworthy insider purchase on June 23,. What Happened: In a recent Form 4 filing with the U.S.

Noteworthy Insider Activity: William A Hawkins Invests $185K In MiMedx Group Stock - MiMedx Group ( NASDAQ:MDXG )

https://www.benzinga.com/insights/news/25/06/46076598/noteworthy-insider-activity-william-a-hawkins-invests-185k-in-mimedx-group-stock
It was revealed in a recent SEC filing that William A Hawkins, Board Member at MiMedx Group MDXG made a noteworthy insider purchase on June 23,. What Happened: In a recent Form 4 filing with the U.S.

Positive Signal: James L Bierman Shows Faith, Buying $185K In MiMedx Group Stock - MiMedx Group ( NASDAQ:MDXG )

https://www.benzinga.com/insights/news/25/06/46076594/positive-signal-james-l-bierman-shows-faith-buying-185k-in-mimedx-group-stock
A new SEC filing reveals that James L Bierman, Board Member at MiMedx Group MDXG, made a notable insider purchase on June 23,. What Happened: A Form 4 filing with the U.S. Securities and Exchange Commission on Monday unveiled that Bierman made a notable purchase of 28,609 shares of MiMedx Group, ...
Advertisement

William F. Hulse as attorney-in-factM. Kathleen Behrens Wilsey's Recent Buy: Acquires $185K In MiMedx Group Stock - MiMedx Group ( NASDAQ:MDXG )

https://www.benzinga.com/insights/news/25/06/46076585/william-f-hulse-as-attorney-in-factm-kathleen-behrens-wilseys-recent-buy-acquires-185k-in-mimedx-gr
In a recent SEC filing, it was revealed that William F. Hulse as attorney-in-factM. Kathleen Behrens Wilsey, Board Member at MiMedx Group MDXG, made a noteworthy insider purchase on June 23,. What Happened: Wilsey's recent move, as outlined in a Form 4 filing with the U.S.

Bullish Move: Todd Newton Shows Confidence, Acquires $185K In MiMedx Group Stock - MiMedx Group ( NASDAQ:MDXG )

https://www.benzinga.com/insights/news/25/06/46076577/bullish-move-todd-newton-shows-confidence-acquires-185k-in-mimedx-group-stock
A significant insider buy by Todd Newton, Board Member at MiMedx Group MDXG, was executed on June 23, and reported in the recent SEC filing. What Happened: In a Form 4 filing on Monday with the U.S.

Spectral AI Announces Appointment of Stanley Micek as Chief Operating Officer

https://www.globenewswire.com/news-release/2025/05/30/3091011/0/en/Spectral-AI-Announces-Appointment-of-Stanley-Micek-as-Chief-Operating-Officer.html
DALLAS, May 30, 2025 ( GLOBE NEWSWIRE ) -- Spectral AI, Inc. ( Nasdaq: MDAI ) ( "Spectral AI" or the "Company" ) , an artificial intelligence ( AI ) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Stanley Micek has been ...

MediWound ( MDWD ) Q1 2025 Earnings Call Transcript

https://www.fool.com/earnings/call-transcripts/2025/05/21/mediwound-mdwd-q1-2025-earnings-call-transcript/
Image source: The Motley Fool.Wednesday, May 21, 2025, at 8:30 a.m. EDTChief Executive Officer - Ofer GonenContinue reading ...

MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update

https://www.globenewswire.com/news-release/2025/05/21/3085601/30505/en/MediWound-Reports-First-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html
VALUE Phase III trial of EscharEx® in venous leg ulcers advancing as planned ...
Advertisement

MiMedx ( MDXG ) Q1 Earnings Match Estimates

https://www.zacks.com/stock/news/2459425/mimedx-mdxg-q1-earnings-match-estimates
MiMedx (MDXG) delivered earnings and revenue surprises of 0% and 2.56%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

MIMEDX to Host First Quarter 2025 Operating and Financial Results Conference Call on April 30

https://www.globenewswire.com/news-release/2025/04/16/3062478/0/en/MIMEDX-to-Host-First-Quarter-2025-Operating-and-Financial-Results-Conference-Call-on-April-30.html
MARIETTA, Ga., April 16, 2025 ( GLOBE NEWSWIRE ) -- MiMedx Group, Inc. ( Nasdaq: MDXG ) ( "MIMEDX" or the "Company" ) today announced that it will report its operating and financial results for the first quarter ended March 31, 2025 after the market close on Wednesday, April 30, 2025.

Bioactive Dressings Market Poised for Growth Amid Rising Chronic Wound Cases and Advanced Wound Care Innovations: Verified Market Research®

https://www.benzinga.com/pressreleases/25/04/g44736025/bioactive-dressings-market-poised-for-growth-amid-rising-chronic-wound-cases-and-advanced-wound-ca
Lewes, Delaware, April 10, 2025 ( GLOBE NEWSWIRE ) -- The Global Bioactive Dressings Market Size is projected to grow at a CAGR of 10.7% from 2025 to 2032, according to a new report published by Verified Market Research®.

BioHarvest Sciences Inc. ( BHST ) Reports Q4 Loss, Lags Revenue Estimates

https://www.zacks.com/stock/news/2437700/bioharvest-sciences-inc-bhst-reports-q4-loss-lags-revenue-estimates
BioHarvest Sciences Inc. (BHST) delivered earnings and revenue surprises of -41.67% and 1.05%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Strength Seen in Sarepta Therapeutics ( SRPT ) : Can Its 8.7% Jump Turn into More Strength?

https://www.zacks.com/stock/news/2432500/strength-seen-in-sarepta-therapeutics-srpt-can-its-87-jump-turn-into-more-strength
Sarepta Therapeutics (SRPT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Advertisement

MIMEDX to Present at TD Cowen 45th Annual Health Care Conference - MiMedx Group ( NASDAQ:MDXG )

https://www.benzinga.com/pressreleases/25/02/g44004107/mimedx-to-present-at-td-cowen-45th-annual-health-care-conference
MARIETTA, Ga., Feb. 27, 2025 ( GLOBE NEWSWIRE ) -- MiMedx Group, Inc. MDXG ( "MIMEDX" or the "Company" ) today announced that senior management will participate in the TD Cowen 45th Annual Health Care Conference.

MiMedx ( MDXG ) Q4 Earnings Meet Estimates

https://www.zacks.com/stock/news/2422296/mimedx-mdxg-q4-earnings-meet-estimates
MiMedx (MDXG) delivered earnings and revenue surprises of 0% and 6.79%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

https://www.globenewswire.com/news-release/2025/02/12/3024885/30505/en/MediWound-Initiates-the-VALUE-Global-Phase-III-Pivotal-Trial-of-EscharEx-for-Treatment-of-Venous-Leg-Ulcers.html
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure ...

Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Allurion Technologies ( NYSE:ALUR ) , Aclarion ( NASDAQ:ACON )

https://www.benzinga.com/25/01/43222003/why-logility-supply-chain-solutions-shares-are-trading-higher-by-over-23-here-are-20-stocks-moving-premarket
Shares of Logility Supply Chain Solutions, Inc. LGTY rose sharply in today's pre-market trading after Aptean announced an agreement to acquire Logility in a $14.30-per-share all-cash deal. Logility Supply Chain Solutions shares jumped 23.2% to $13.95 in the pre-market trading session.

JB Hunt Transport Posts Weak Earnings, Joins JetBlue Airways And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Alvotech ( NASDAQ:ALVO ) , Alumis ( NASDAQ:ALMS )

https://www.benzinga.com/trading-ideas/movers/25/01/43054371/jb-hunt-transport-posts-weak-earnings-joins-jetblue-airways-and-other-big-stocks-moving-lowe
U.S. stock futures were higher this morning, with the Dow futures gaining over 100 points on Friday. Shares of J.B. Hunt Transport Services, Inc. JBHT fell sharply in today's pre-market trading as the company reported weaker-than-expected earnings for its fourth quarter on Thursday.
Advertisement

Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket - Alvotech ( NASDAQ:ALVO ) , Beasley Broadcast Group ( NASDAQ:BBGI )

https://www.benzinga.com/25/01/43050714/why-versus-systems-shares-are-trading-higher-by-around-71-here-are-20-stocks-moving-premarket
Shares of Versus Systems Inc. VS rose sharply in today's pre-market trading after the company announced expansion into the Brazilian market as part of its strategy to grow its international footprint. Versus Systems shares jumped 71.2% to $3.39 in the pre-market trading session.

Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket - Alvotech ( NASDAQ:ALVO ) , Beasley Broadcast Group ( NASDAQ:BBGI )

https://www.benzinga.com/trading-ideas/movers/25/01/43050714/why-versus-systems-shares-are-trading-higher-by-around-71-here-are-20-stocks-moving-premarke
Shares of Versus Systems Inc. VS rose sharply in today's pre-market trading after the company announced expansion into the Brazilian market as part of its strategy to grow its international footprint. Versus Systems shares jumped 71.2% to $3.39 in the pre-market trading session.

Poseida Therapeutics, Inc. ( PSTX ) Hits Fresh High: Is There Still Room to Run?

https://www.zacks.com/stock/news/2383276/poseida-therapeutics-inc-pstx-hits-fresh-high-is-there-still-room-to-run
Poseida Therapeutics (PSTX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

MIMEDX to Participate in Upcoming Investor Conferences - MiMedx Group ( NASDAQ:MDXG )

https://www.benzinga.com/pressreleases/24/12/g42312770/mimedx-to-participate-in-upcoming-investor-conferences
MARIETTA, Ga., Dec. 04, 2024 ( GLOBE NEWSWIRE ) -- MiMedx Group, Inc. MDXG ( "MIMEDX" or the "Company" ) today announced that members of its senior management will participate in the following investor conferences: Mizuho Health Care Conference Wednesday, December 11, 2024 1:1 sessions | ...

Poseida Therapeutics, Inc. ( PSTX ) Hit a 52 Week High, Can the Run Continue?

https://www.zacks.com/stock/news/2375920/poseida-therapeutics-inc-pstx-hit-a-52-week-high-can-the-run-continue
Poseida Therapeutics (PSTX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Advertisement

How Much Upside is Left in MiMedx ( MDXG ) ? Wall Street Analysts Think 37.12%

https://www.zacks.com/stock/news/2372802/how-much-upside-is-left-in-mimedx-mdxg-wall-street-analysts-think-3712
The mean of analysts' price targets for MiMedx (MDXG) points to a 37.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

MIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs

https://www.globenewswire.com/news-release/2024/11/14/2981300/0/en/MIMEDX-s-Advocacy-to-Rein-in-Runaway-Medicare-Spend-for-Skin-Substitutes-Has-Yielded-Significant-Results-with-Planned-Implementation-of-LCDs.html
Over 200 Unproven Skin Substitutes Will No Longer Be Covered Under Revised ...

ChromaDex Corporation ( CDXC ) Hit a 52 Week High, Can the Run Continue?

https://www.zacks.com/stock/news/2364265/chromadex-corporation-cdxc-hit-a-52-week-high-can-the-run-continue
ChromaDex (CDXC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Can MiMedx ( MDXG ) Climb 77.92% to Reach the Level Wall Street Analysts Expect?

https://www.zacks.com/stock/news/2363476/can-mimedx-mdxg-climb-7792-to-reach-the-level-wall-street-analysts-expect
The consensus price target hints at a 77.9% upside potential for MiMedx (MDXG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

MiMedx ( MDXG ) Q3 Earnings and Revenues Surpass Estimates

https://www.zacks.com/stock/news/2361048/mimedx-mdxg-q3-earnings-and-revenues-surpass-estimates
MiMedx (MDXG) delivered earnings and revenue surprises of 40% and 3.77%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Advertisement

MIMEDX Announces Third Quarter 2024 Operating and Financial Results

https://www.globenewswire.com/news-release/2024/10/30/2972036/0/en/MIMEDX-Announces-Third-Quarter-2024-Operating-and-Financial-Results.html
Net Sales of $84 million Grew 3% Year-Over-Year for the Third QuarterThird Quarter GAAP Net Income and Earnings Per Share were $8 Million and $0.05, RespectivelyThird Quarter Adjusted EBITDA was $18 Million, or 22% of Net SalesRaises 2024 Net Sales Growth Expectations to the High ...

MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue - MiMedx Group ( NASDAQ:MDXG )

https://www.benzinga.com/pressreleases/24/10/g41238720/mimedx-points-to-the-new-york-times-article-on-the-vast-benefits-of-placental-tissue
MARIETTA, Ga., Oct. 08, 2024 ( GLOBE NEWSWIRE ) -- MiMedx Group, Inc. MDXG ( "MIMEDX" or the "Company" ) today highlighted the publication of a feature article on placental allografts for patients with hard-to-heal, acute and chronic wounds, which was published in today's New York Times: "Her ...

MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix - MiMedx Group ( NASDAQ:MDXG )

https://www.benzinga.com/pressreleases/24/07/g40080497/mimedx-announces-launch-of-heliogen-fibrillar-collagen-matrix
MARIETTA, Ga., July 31, 2024 ( GLOBE NEWSWIRE ) -- MiMedx Group, Inc. MDXG ( "MIMEDX" or the "Company" ) today announced the commercial launch of HELIOGEN™ Fibrillar Collagen Matrix, a particulate xenograft product aimed at addressing complex wounds primarily in the surgical setting.

MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature - Scientific Reports

https://www.globenewswire.com/news-release/2024/07/22/2916510/0/en/MIMEDX-Announces-Publication-Focused-on-Surgical-Applications-Using-MIMEDX-Placental-Based-Allografts-in-Nature-Scientific-Reports.html
Study adds to the Company's growing body of evidence and expands the understanding of the regulatory capabilities of its DHACM and LHACM allografts on the fibrotic process ...

Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives

https://www.globenewswire.com/news-release/2024/07/17/2914481/8339/en/Cassava-Sciences-Announces-Changes-in-Executive-Leadership-Enhanced-Corporate-Governance-and-Other-Initiatives.html
AUSTIN, Texas, July 17, 2024 ( GLOBE NEWSWIRE ) -- Cassava Sciences, Inc. ( Nasdaq: SAVA ) today announced that the Board of Directors has appointed Richard ( Rick ) Barry as Executive Chairman of the Board and as the Company's principal executive officer, effective immediately.
Advertisement

MiMedx Group ( NASDAQ:MDXG ) Rating Increased to Strong-Buy at StockNews.com

https://www.defenseworld.net/2024/07/11/mimedx-group-nasdaqmdxg-rating-increased-to-strong-buy-at-stocknews-com.html
MiMedx Group ( NASDAQ:MDXG - Get Free Report ) was upgraded by equities researchers at StockNews.com from a "buy" rating to a "strong-buy" rating in a research report issued on Thursday. Several other brokerages also recently commented on MDXG. Cantor Fitzgerald initiated coverage on MiMedx ...

MiMedx Group ( NASDAQ:MDXG ) Downgraded by StockNews.com to "Buy"

https://www.defenseworld.net/2024/07/04/mimedx-group-nasdaqmdxg-downgraded-by-stocknews-com-to-buy.html
StockNews.com downgraded shares of MiMedx Group ( NASDAQ:MDXG - Free Report ) from a strong-buy rating to a buy rating in a research note published on Wednesday morning. A number of other equities analysts have also recently issued reports on MDXG. Cantor Fitzgerald assumed coverage on shares ...

MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer

https://www.globenewswire.com/news-release/2024/06/26/2904805/0/en/MIMEDX-Announces-the-Appointment-of-Kim-Moller-to-Chief-Commercial-Officer.html
MARIETTA, Ga., June 26, 2024 ( GLOBE NEWSWIRE ) -- MiMedx Group, Inc. ( Nasdaq: MDXG ) ( "MIMEDX" or the "Company" ) today announced the appointment of Kim Moller to Chief Commercial Officer. Ms. Moller has been serving as the Company's Senior Vice President, Sales since August 2020.

MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer - MiMedx Group ( NASDAQ:MDXG )

https://www.benzinga.com/pressreleases/24/06/g39511716/mimedx-announces-the-appointment-of-kim-moller-to-chief-commercial-officer
MARIETTA, Ga., June 26, 2024 ( GLOBE NEWSWIRE ) -- MiMedx Group, Inc. MDXG ( "MIMEDX" or the "Company" ) today announced the appointment of Kim Moller to Chief Commercial Officer. Ms. Moller has been serving as the Company's Senior Vice President, Sales since August 2020.

Entrepreneur, Public Company CEO, and Philanthropist Parker H. "Pete" Petit Releases New Book "The Entrepreneur's ... - PR Newswire

https://www.prnewswire.com/news-releases/entrepreneur-public-company-ceo-and-philanthropist-parker-h-pete-petit-releases-new-book-the-entrepreneurs-dilemma-should-i-take-my-company-public-302183431.html
Entrepreneur, Public Company CEO, and Philanthropist Parker H. "Pete" Petit Releases New Book "The Entrepreneur's ... PR ...
Advertisement

Entrepreneur, Public Company CEO, and Philanthropist Parker H. "Pete" Petit Releases New Book "The Entrepreneur's Dilemma: Should I Take My Company Public?"

https://www.benzinga.com/pressreleases/24/06/n39507517/entrepreneur-public-company-ceo-and-philanthropist-parker-h-pete-petit-releases-new-book-the-entre
ATLANTA, June 26, 2024 /PRNewswire/ -- Parker H. "Pete" Petit, an experienced entrepreneur, public company CEO and philanthropist, announces the launch of his new book, "The Entrepreneur's Dilemma: Should I Take My Company Public?" This compelling first-person account chronicles Petit's thrust ...

MiMedx Group ( NASDAQ:MDXG ) Upgraded by StockNews.com to "Strong-Buy"

https://www.defenseworld.net/2024/06/04/mimedx-group-nasdaqmdxg-upgraded-by-stocknews-com-to-strong-buy.html
StockNews.com upgraded shares of MiMedx Group ( NASDAQ:MDXG - Free Report ) from a buy rating to a strong-buy rating in a research report sent to investors on Monday. Other analysts have also issued reports about the company.

Spectral AI Announces Voting Results from 2024 Annual Meeting of Stockholders and the Appointment of Erich Spangenberg to the Board of Directors - Spectral AI ( NASDAQ:MDAIW ) , Spectral AI ( NASDAQ:MDAI )

https://www.benzinga.com/pressreleases/24/05/g38860891/spectral-ai-announces-voting-results-from-2024-annual-meeting-of-stockholders-and-the-appointment-
DALLAS, May 15, 2024 ( GLOBE NEWSWIRE ) -- Spectral AI, Inc. MDAI ( "Spectral AI" or the "Company" ) , an artificial intelligence ( AI ) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced results from its 2024 Annual Meeting of ...

Spectral AI Announces Voting Results from 2024 Annual Meeting of Stockholders and the Appointment of Erich Spangenberg to the Board of Directors

https://www.globenewswire.com/news-release/2024/05/15/2883007/0/en/Spectral-AI-Announces-Voting-Results-from-2024-Annual-Meeting-of-Stockholders-and-the-Appointment-of-Erich-Spangenberg-to-the-Board-of-Directors.html
DALLAS, May 15, 2024 ( GLOBE NEWSWIRE ) -- Spectral AI, Inc. ( Nasdaq: MDAI ) ( "Spectral AI" or the "Company" ) , an artificial intelligence ( AI ) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced results from its 2024 Annual ...

MIMEDX to Participate in Upcoming Investor Conferences

https://www.globenewswire.com/news-release/2024/05/15/2882353/0/en/MIMEDX-to-Participate-in-Upcoming-Investor-Conferences.html
MARIETTA, Ga., May 15, 2024 ( GLOBE NEWSWIRE ) -- MiMedx Group, Inc. ( Nasdaq: MDXG ) ( "MIMEDX" or the "Company" ) today announced that members of its senior management will participate in the following investor conferences: ...
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion